Core Insights - Brain-computer interface (BCI) technology is revolutionizing treatment for patients with conditions previously deemed untreatable, such as paralysis, Parkinson's disease, and blindness, by establishing new neural pathways between the brain and external devices [1] - The Chinese government has released supportive policies aimed at enhancing the BCI industry, with a goal to cultivate 2 to 3 globally influential leading companies and a number of specialized small and medium enterprises by 2030 [1] - The 2025 China International Import Expo showcased several leading global companies presenting cutting-edge BCI innovations, indicating strong momentum in the industry [1] Industry Developments - The precision of electrode placement in the brain is critical for BCI technology, as any minor deviation during surgery can lead to permanent damage to patients' language, movement, or cognitive functions [2] - Siemens Healthineers introduced a comprehensive BCI solution at the expo, which integrates advanced imaging technologies for preoperative planning, intraoperative navigation, and postoperative assessment, facilitating the transition of BCI from research to clinical application [2] - Key imaging devices showcased include the MAGNETOM Cima.X MRI, NAEOTOM Alpha CT, and ARTIS icono ceiling Xpand, which provide a robust imaging platform for BCI surgeries [2] Product Innovations - The devices presented have been successfully utilized in Neuralink's clinical trials, enhancing the precision and safety of invasive BCI surgeries [3] - Medtronic's Percept RC, a rechargeable and sensing closed-loop brain stimulator, represents a significant advancement in the field, enabling real-time analysis of brain activity for personalized treatment [3] - The Percept RC made its debut in China at the expo, promising to offer advanced treatment options for patients with Parkinson's disease and other neurological disorders, marking a new era in neuroregulation and BCI technology [3]